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We discuss a case of a 64-year-old male with a history of liver failure presenting with altered mental
status, initially diagnosed with hepatic encephalopathy but ultimately diagnosed with nonconvulsive
status epilepticus (NCSE) by electroencephalogram (EEG). NCSE is a difficult diagnosis to make,
given no clear consensus on diagnostic criteria. Especially in the intensive care unit setting of
persistent altered mental status with no clear etiology, NCSE must be considered in the differential
diagnosis, as the consequences of delayed diagnosis and treatment can be substantial. EEG can be
useful in the evaluation of patients with hepatic encephalopathy who have persistently altered levels of
consciousness despite optimal medical management. [West J Emerg Med. 2011;12(4):372–374.]
INTRODUCTION
Hepatic encephalopathy is a well-recognized and
commonly diagnosed syndrome that has been researched and
discussed for many years. Typically, hepatic encephalopathy is
associated with advanced chronic liver disease and its clinical
manifestations range from sleep disturbance to confusion or
coma.
1 In rare cases, hepatic encephalopathy presents with
overt seizure activity.
2
Similarly, status epilepticus (SE) is a commonly diagnosed
condition. While the dramatic tonic clonic features of SE are
easily recognized, nonconvulsive status epilepticus (NCSE), a
type of SE, tends to be underrecognized because of its inherent
lack of discrete clinical signs.
3–5 While a few case reports have
been published describing patients with hepatic
encephalopathy presenting in SE, herewe describe the case of a
patient presenting with hepatic encephalopathy and ultimately
diagnosed with NCSE.
CASE REPORT
A 64-year-old man with a history of hypertension, chronic
kidney disease, and liver failure secondary to hepatitis C, with
status post liver transplant 13 years priorly, was brought in by
ambulance to the emergency department for acutely altered
mental status. The patient had been in his usual state of health,
until he told his family 3 hours before that he ‘‘felt sick.’’ The
family incidentally found him on the ﬂoor, confused and
lethargic, and immediately called the ambulance.
Upon arrival, the patient had a temperature of 96.48F;
pulse, 117 beats per minute; blood pressure, 151/93 mmHg;
respiratory rate, 22 breaths per minute; and oxygen saturation
of 100% on nonrebreather. The patient was known to have a
history of recurrent episodes of hepatic encephalopathy, and his
last episode of hepatic encephalopathy was in the prior 3
months, which was treated and controlled with lactulose. The
patient’s family stated that the patient had run out of lactulose 4
days before presentation. Other than lactulose, the patient was
compliant with all of his home medications, including
amlodipine, buproprion, cyclosporine, hydrocodone, lasix,
methocarbamol, and ramipril. The patient had no known
history of seizure, recent illness, brain trauma, or recent
surgical procedures.
Physical examination showed a male in no acute distress
with a Glasgow Coma Scale of 12 (eyes, 4; verbal, 3; motor, 5).
There were no signs of trauma found on his body. His pupils
were equally round and reactive to light, and his neck was
supple and soft with a cervical collar in place.
Cardiopulmonary examination was unremarkable except for
tachycardia. Abdominal examination was unremarkable.
Because he was not following commands, the neurologic
examination was limited. However, the patient was able to
move all extremities equally and pulses were distally equal to
all extremities. There was no posturing or clonus noted, and
Babinski was downgoing in both feet.
Fingerstick glucose level was 210 mg/dL and bedside
hemoglobin level was 13.1 g/dL. Noncontrast head and
cervical spine computed tomography revealed no acute
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pathologic lesion. Laboratory tests showed white blood cell
counts of 5.5 K/mm
3 with 60% neutrophils, hematocrit of
36.5%, and platelets of 115 K/mm
3. Electrolyte and liver
function results were as follows: sodium, 141 mmol/L;
potassium, 3.5 mmol/L; chloride, 104 mmol/L; bicarbonate,
22 mmol/L; calcium, 9.3 mg/dL; blood urea nitrogen, 71
mmol/L; creatinine, 1.9 mg/dL; total bilirubin, 2.1 mg/dL;
aspartate aminotransferase, 128 U/L; alanine
aminotransferase, 124 U/L; alkaline phosphatase, 231 U/L;
albumin, 4.0 g/dL; lipase, 30 U/L; prothrombin time, 14.5
seconds; INR, 1.09; and ammonia, 501 lmol/L (reference
range, 15–55 lmol/L). Toxicology serum screen results were
negative for acetaminophen, salicylate, and ethanol. Urine
toxicology screen results were positive only for opiates.
Venous blood gas was pH 7.44.
Owing to the patient’s obtunded condition and inability to
protect his airway, the patient was electively intubated and
given midazolam drip for sedation. The patient was admitted to
the intensive care unit (ICU) for monitoring with a presumed
diagnosis of hepatic encephalopathy. While administration of
empiric antibiotics was started in the emergency department, it
was discontinued after an infectious etiology was deemed
unlikely and culture results were negative. Results of a
magnetic resonance imaging brain scan were also negative,
including no evidence of infarct.
During the ICU stay, the patient was readministered
lactulose, and ammonia levels decreased to117 lmol/L by
hospital day 2 and to 78 lmol/L by hospital day 4. Despite
discontinuation of sedation, the patient remained unresponsive.
A neurologist was consulted and a bedside
electroencephalogram (EEG) revealed ﬁndings consistent with
status epilepticus. However, the patient had no clinical
manifestations of status epilepticus, leading to a diagnosis of
nonconvulsive status epilepticus. A phenytoin load was
immediately administered, while a midazolam infusion was
restarted, ultimately leading to EEG resolution of the status
epilepticus. The patient did not immediately improve
neurologically during the hospitalization stay and was
ultimately transferred to another facility for continued
treatment and rehabilitation.
DISCUSSION
Nonconvulsive status epilepticus has long been an
underdiagnosed condition for a variety of reasons. Owing to its
pleomorphic clinical presentation and its ultimate reliance on
EEG for deﬁnitive diagnosis, NCSE has often been overlooked
by physicians. Additionally, NCSE has undergone several
changes in deﬁnition, reﬂecting our relative lack of
understanding and the complexity of this disease process. In
2004, the Epilepsy Research Foundation consensus workshop
deﬁned NCSE as ‘‘a term used to denote a range of conditions
in which electrographic seizure activity is prolonged and results
in nonconvulsive clinical symptoms.’’
6 Diagnostic criteria for
NCSE continue to be debated. The clinical presentation of
NCSE varies greatly, from subtle behavioral changes to
persistent confusional state to coma.
3 EEG diagnostic criteria
have also been the subject of vigorous debate.
6 While the
diagnostic criteria continue to be contested, many agree that
NCSE is an underdiagnosed entity. A recent study of 236
comatose patients, with no overt clinical seizure activity and
receiving EEG, found that 8% of those patients met the criteria
for NCSE.
7 Nonconvulsive status epilepticus itself
encompasses several different subtypes, including but not
limited to, absence status epilepticus, simple partial status
epilepticus, complex partial status epilepticus, and
nonconvulsive status epilepticus in coma.
4
This particular case highlights the difﬁculty in diagnosing
NCSE, especially in the setting of a seeminglyobvious etiology
for altered mental status, namely, hepatic encephalopathy.
Although case reports have documented patients with hepatic
encephalopathy presenting with generalized convulsive SE,
8,9 a
literature search at the time of this publication has revealed no
published cases of NCSE in the setting of hepatic
encephalopathy.
The pathophysiology underlying the development of
seizures in the setting of hepatic encephalopathy remains
unknown. Various metabolic factors are most likely involved,
including short chain fatty acids, mercaptans, phenols, and
false neurotransmitters.
10 Hyperammonemia is likely a
contributing factor, as triphasic waves and epileptiform
abnormalities on EEG is a well-documented ﬁnding in hepatic
encephalopathy and hyperammonemia.
2,11,12 The association
between hyperammonemia and seizures has further been
highlighted by Velioglu et al,
13 who discussed the case of a
patient with no underlying hepatobiliary conditions who
developed NCSE secondary to valproic acid–induced
hyperammonemia.
There are other precipitant events or conditions in the
setting of hepatobiliary disease that may contribute to the
development of seizures. These include metabolic derangement
from large-volume paracentesis or from acute decompensation
of liver failure, and complications from recent liver transplant
or from transjugular intrahepatic portal systemic shunt
placement. Particularly in the unique setting of liver transplant,
Wszolek et al
14 reported in a retrospective chart review that
29% of 69 liver transplant patients had epileptiform
abnormalities seen on EEG and ultimately died. The authors
concluded that EEG epileptiform abnormalities after liver
transplant, were ‘‘associated with serious, often irreversible,
brain damage.’’
In this particular case, there were no overt precipitating
factors leading to the patient’s ultimate diagnosis of NCSE,
other than noncompliance with medication. Unfortunately, the
patient was presumably in NCSE for a signiﬁcant period of
time before the diagnosis was made. While morbidity and
mortality remain high in patients with severe hepatic
encephalopathy, this case highlights the reality of NCSE
underlying hepatic encephalopathy and the importance and
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KEY POINTS
Nonconvulsive status epilepticus encompasses a wide
range of diagnoses with no clear consensus on diagnostic
criteria.
Nonconvulsive status epilepticus is a difﬁcult diagnosis to
make and requires a high index of suspicion.
Especially in the ICU setting of unresolving altered mental
status with no clear etiology, NCSE must be considered in the
differential diagnosis, as the consequences of delayed diagnosis
and treatment can be substantial.
Emergent EEG can be useful in the evaluation of patients
with hepatic encephalopathy who have alterations in levels of
consciousness.
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